{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:15:48Z","timestamp":1793646948941,"version":"4.5.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymgmr.2024.101142","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:09:42Z","timestamp":1726510182000},"page":"101142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MADD-like pattern of acylcarnitines associated with sertraline use"],"prefix":"10.1016","volume":"41","author":[{"given":"Filippo","family":"Ingoglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tanfous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ellezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo D.","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2024.101142_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03047371","article-title":"Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency)","volume":"7","author":"Goodman","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"issue":"13","key":"10.1016\/j.ymgmr.2024.101142_bb0010","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1073\/pnas.82.13.4517","article-title":"Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts","volume":"82","author":"Frerman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgmr.2024.101142_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105899","article-title":"Disorders of flavin adenine dinucleotide metabolism: MADD and related deficiencies","volume":"132","author":"Mereis","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgmr.2024.101142_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-014-0117-5","article-title":"Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme a dehydrogenase deficiency","volume":"9","author":"Grunert","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2024.101142_bb0025","series-title":"GeneReviews((R)), Seattle (WA)","article-title":"Multiple Acyl-CoA dehydrogenase deficiency","author":"Prasun","year":"1993"},{"key":"10.1016\/j.ymgmr.2024.101142_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.815523","article-title":"Diagnostic challenges in late onset multiple acyl-CoA dehydrogenase deficiency: clinical, morphological, and genetic aspects","volume":"13","author":"Lupica","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgmr.2024.101142_bb0035","series-title":"StatPearls","article-title":"Sertraline","author":"Singh","year":"2023"},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101142_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/toxsci\/kfs100","article-title":"Mitochondrial dysfunction induced by sertraline, an antidepressant agent","volume":"127","author":"Li","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"70","key":"10.1016\/j.ymgmr.2024.101142_bb0045","doi-asserted-by":"crossref","first-page":"115490","DOI":"10.18632\/oncotarget.23302","article-title":"Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes","volume":"8","author":"Then","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymgmr.2024.101142_bb0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fnins.2018.00386","article-title":"Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression","volume":"12","author":"Allen","year":"2018","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101142_bb0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jimd.12058","article-title":"Disorders of riboflavin metabolism","volume":"42","author":"Balasubramaniam","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2024.101142_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jad.2019.11.122","article-title":"Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes","volume":"264","author":"Ahmed","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101142_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41398-020-01097-6","article-title":"Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression","volume":"11","author":"MahmoudianDehkordi","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101142_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2016.15111500","article-title":"Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"174","author":"Pan","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ymgmr.2024.101142_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mito.2016.10.005","article-title":"Drug induced mitochondrial dysfunction: mechanisms and adverse clinical consequences","volume":"31","author":"Vuda","year":"2016","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101142_bb0080","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1097\/MJT.0000000000001540","article-title":"Sertraline-associated rhabdomyolysis","volume":"30","author":"Cottone","year":"2023","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101142_bb0085","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1097\/MJT.0000000000000196","article-title":"Sertraline-induced rhabdomyolysis: a case report and literature review","volume":"23","author":"Snyder","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ymgmr.2024.101142_bb0090","article-title":"Multiple acyl-coenzyme a dehydrogenase deficiency is associated with Sertraline use - is there an acquired form?","author":"Sunebo","year":"2024","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101142_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108516","article-title":"Molecular genetic analysis of candidate genes for glutaric aciduria type II in a cohort of patients from Queensland, Australia","volume":"142","author":"Demetriou","year":"2024","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T14:15:51Z","timestamp":1734358551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"alternative-id":["S2214426924000958"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101142","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MADD-like pattern of acylcarnitines associated with sertraline use","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101142"}}